Inovio pharmaceuticals reports third quarter results

Inovio pharmaceuticals reports 2019 third quarter financial results.q3 loss per share $0.25.q3 revenue $867,000 versus $2.0 million.q3 revenue estimate $3.9 million -- refinitiv ibes data.q3 earnings per share estimate $-0.26 -- refinitiv ibes data.inovio pharmaceuticals - as of sept 30, 2019, cash and cash equivalents and short-term investments were $93.8 million versus $81.2 million as of dec 31, 2018.
INO Ratings Summary
INO Quant Ranking